Related references
Note: Only part of the references are listed.RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer
Lei Sun et al.
GUT (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
p53 transcriptionally regulates SQLE to repress cholesterol synthesis and tumor growth
Huishan Sun et al.
EMBO REPORTS (2021)
LINC01348 suppresses hepatocellular carcinoma metastasis through inhibition of SF3B3-mediated EZH2 pre-mRNA splicing
Yang-Hsiang Lin et al.
ONCOGENE (2021)
Cancer metabolism: looking forward
Inmaculada Martinez-Reyes et al.
NATURE REVIEWS CANCER (2021)
Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans
Li Che et al.
GUT (2020)
A TGF-beta-MTA1-SOX4-EZH2 signaling axis drives epithelial-mesenchymal transition in tumor metastasis
Lina Li et al.
ONCOGENE (2020)
Collaborative interactions of heterogenous ribonucleoproteins contribute to transcriptional regulation of sterol metabolism in mice
Zhengyi Zhang et al.
NATURE COMMUNICATIONS (2020)
Regulation of cellular sterol homeostasis by the oxygen responsive noncoding RNA lincNORS
Xue Wu et al.
NATURE COMMUNICATIONS (2020)
Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities
Binlu Huang et al.
NATURE METABOLISM (2020)
Transcriptome-Wide Analysis Reveals the Landscape of Aberrant Alternative Splicing Events in Liver Cancer
Shengli Li et al.
HEPATOLOGY (2019)
Dangerous liaisons: interplay between SWI/SNF, NuRD, and Polycomb in chromatin regulation and cancer
Adrian P. Bracken et al.
GENES & DEVELOPMENT (2019)
MTA1-Dependent Anticancer Activity of Gnetin C in Prostate Cancer
Avinash Kumar et al.
NUTRIENTS (2019)
p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression
Sung-Hwan Moon et al.
CELL (2019)
Oxysterols in intestinal immunity and inflammation
T. Willinger
JOURNAL OF INTERNAL MEDICINE (2019)
MTA1 is a novel regulator of autophagy that induces tamoxifen resistance in breast cancer cells
Min-Ho Lee et al.
AUTOPHAGY (2018)
Overexpression of RALY promotes migration and predicts poor prognosis in hepatocellular carcinoma
Zebin Zhu et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer
Ke Chen et al.
CLINICAL CANCER RESEARCH (2017)
RNA binding protein RALY promotes Protein Arginine Methyltransferase 1 alternatively spliced isoform v2 relative expression and metastatic potential in breast cancer cells
Emma Bondy-Chorney et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2017)
The hnRNP RALY regulates transcription and cell proliferation by modulating the expression of specific factors including the proliferation marker E2F1
Nicola Cornella et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
A pathology atlas of the human cancer transcriptome
Mathias Uhlen et al.
SCIENCE (2017)
Regulatory Expansion in Mammals of Multivalent hnRNP Assemblies that Globally Control Alternative Splicing
Serge Gueroussov et al.
CELL (2017)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
The hnRNP family: insights into their role in health and disease
Thomas Geuens et al.
HUMAN GENETICS (2016)
Feedback modulation of cholesterol metabolism by the lipid-responsive non-coding RNA LeXis
Tamer Sallam et al.
NATURE (2016)
The interplay between cell signalling and the mevalonate pathway in cancer
Peter J. Mullen et al.
NATURE REVIEWS CANCER (2016)
RNA splicing factors as oncoproteins and tumour suppressors
Heidi Dvinge et al.
NATURE REVIEWS CANCER (2016)
Mechanisms and Regulation of Alternative Pre-mRNA Splicing
Yeon Lee et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 84 (2015)
Structure and function insights into the NuRD chromatin remodeling complex
Morgan P. Torchy et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Role of MTA1 in cancer progression and metastasis
Nirmalya Sen et al.
CANCER AND METASTASIS REVIEWS (2014)
Proteome-Wide Characterization of the RNA-Binding Protein RALY-Interactome Using the in Vivo-Biotinylation-Pulldown-Quant (iBioPQ) Approach
Stefan Tenzer et al.
JOURNAL OF PROTEOME RESEARCH (2013)
Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence
Y. Tang et al.
ONCOGENE (2013)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression
Rhonda L. Brown et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
NONO and RALY proteins are required for YB-1 oxaliplatin induced resistance in colon adenocarcinoma cell lines
Serges P. Tsofack et al.
MOLECULAR CANCER (2011)
Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged
Charles J. David et al.
GENES & DEVELOPMENT (2010)
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
Charles J. David et al.
NATURE (2010)
Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches
Mo Chen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA
Daisuke Kaida et al.
NATURE CHEMICAL BIOLOGY (2007)
A positive feedback loop couples Ras activation and CD44 alternative splicing
Chonghui Cheng et al.
GENES & DEVELOPMENT (2006)
VEGF165b, an inhibitory vascular endothelial growth factor splice variant:: Mechanism of action, in vivo effect on angiogenesis and endogenous protein expression
J Woolard et al.
CANCER RESEARCH (2004)
Molecular architecture of the multiprotein splicing factor SF3b
MM Golas et al.
SCIENCE (2003)
Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor
A Mazumdar et al.
NATURE CELL BIOLOGY (2001)
Share Paper
